(Figures 4- 7 in following pages reflect the steady growth of IVL at consolidated level although the regional levels are more cyclical). Business Outlook The doubling of PTA production in The Netherlands
of the Company and the Company’s subsidiaries in the consolidated financial statements for the year ended 31 December 2017, compared to the same period of last year is as follows: Consolidated
consolidated costs of Baht 1,224.26 million, a 6.78% growth over same period of year 2018 whereas the cost of hospital operations, representing 91.82% of the total, increased by 6.03%. This was mainly caused by
result of favorable sales growth in Vietnam and Myanmar markets. Profit for the period L&E’s consolidated profit for the period of Q1/2018 was posted at Baht 19.9 million, up 485 % or Baht 16.5 million
three-month period ended March 31, 2018 was Baht 75.39 million, a growth of 59.82% over same period of previous year, mainly driven by:- Growing consolidated revenues of Baht 436.85 million in Q1/2018
February 18, 2020 Re: Management Discussion and Analysis for full year 2019 To: Director and Manager of the Stock Exchange of Thailand Revenue from sales and rendering of services L&E’s consolidated
November 7, 2018 Re: Management Discussion and Analysis Q3/2018 To: Director and Manager of the Stock Exchange of Thailand Revenue from sales and rendering of services L&E’s consolidated revenue from
Company has other income for fiscal year 2022 amounted 3,277 million baht, 13.5% growth y-y. Details of each business can be described as follows: Profit and Loss Statement Unit : Million Baht Consolidated
”), the subsidiary, has indicated the growth by 12.35%. Costs and Expenses The Company reported the consolidated costs and expenses for Q3/2019 of Baht 365.61 million representing a slightly increase by
subsidiaries for the three- month period ended March 31, 2020. The Company would like to clarify on the operating results as follows: Revenue • For Q1/ 2020, total consolidated revenues advanced to Baht 424.91